ACCC sues Voltaren makers GlaxoSmithKline and Novartis for misleading consumers

Two global pharma giants have been taken to court for allegedly misleading osteoarthritis sufferers into paying more for a “more effective” product that offers “targeted relief”, when this was not the case.

Source link

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.